IRIS Accounts Production v26.2.0.496 08281995 Board of Directors 1.2.25 31.12.25 31.12.25 Medium entities true false true true false false false true false These accounts have been prepared in accordance with the provisions applicable to companies subject to the medium-sized companies regime. Fair value model Ordinary 1.00000 Ordinary A 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh082819952025-01-31082819952025-12-31082819952025-02-012025-12-31082819952024-01-31082819952024-02-012025-01-31082819952025-01-3108281995ns15:EnglandWales2025-02-012025-12-3108281995ns14:PoundSterling2025-02-012025-12-3108281995ns10:Director12025-02-012025-12-3108281995ns10:Director22025-02-012025-12-3108281995ns10:PrivateLimitedCompanyLtd2025-02-012025-12-3108281995ns10:MediumEntities2025-02-012025-12-3108281995ns10:Audited2025-02-012025-12-3108281995ns10:Medium-sizedCompaniesRegimeForDirectorsReport2025-02-012025-12-3108281995ns10:Medium-sizedCompaniesRegimeForAccounts2025-02-012025-12-3108281995ns10:FullAccounts2025-02-012025-12-310828199512025-02-012025-12-3108281995ns10:OrdinaryShareClass12025-02-012025-12-3108281995ns10:OrdinaryShareClass22025-02-012025-12-3108281995ns10:Director32025-02-012025-12-3108281995ns10:Director42025-02-012025-12-3108281995ns10:Director52025-02-012025-12-3108281995ns10:RegisteredOffice2025-02-012025-12-310828199512025-02-012025-12-310828199512024-02-012025-01-3108281995ns5:CurrentFinancialInstruments2025-12-3108281995ns5:CurrentFinancialInstruments2025-01-3108281995ns5:ShareCapital2025-12-3108281995ns5:ShareCapital2025-01-3108281995ns5:SharePremium2025-12-3108281995ns5:SharePremium2025-01-3108281995ns5:RetainedEarningsAccumulatedLosses2025-12-3108281995ns5:RetainedEarningsAccumulatedLosses2025-01-3108281995ns5:ShareCapital2024-01-3108281995ns5:RetainedEarningsAccumulatedLosses2024-01-3108281995ns5:SharePremium2024-01-3108281995ns5:FurtherSpecificReserve1ComponentTotalEquity2024-01-3108281995ns5:RetainedEarningsAccumulatedLosses2024-02-012025-01-3108281995ns5:FurtherSpecificReserve1ComponentTotalEquity2024-02-012025-01-3108281995ns5:FurtherSpecificReserve1ComponentTotalEquity2025-01-3108281995ns5:RetainedEarningsAccumulatedLosses2025-02-012025-12-3108281995ns5:FurtherSpecificReserve1ComponentTotalEquity2025-02-012025-12-3108281995ns5:FurtherSpecificReserve1ComponentTotalEquity2025-12-3108281995ns5:IntangibleAssetsOtherThanGoodwill2025-02-012025-12-3108281995ns5:OwnedOrFreeholdAssetsns5:LandBuildings2025-02-012025-12-3108281995ns5:PlantMachinery2025-02-012025-12-3108281995ns5:FurnitureFittings2025-02-012025-12-3108281995ns5:MotorVehicles2025-02-012025-12-3108281995ns15:UnitedKingdom2025-02-012025-12-3108281995ns15:UnitedKingdom2024-02-012025-01-3108281995ns15:Europe2025-02-012025-12-3108281995ns15:Europe2024-02-012025-01-3108281995ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2025-02-012025-12-3108281995ns5:TotalGeographicSegmentsIncludingAnyUnallocatedAmount2024-02-012025-01-3108281995ns10:HighestPaidDirector2025-02-012025-12-3108281995ns10:HighestPaidDirector2024-02-012025-01-3108281995ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2025-02-012025-12-3108281995ns5:PlantEquipmentOtherAssetsUnderOperatingLeases2024-02-012025-01-3108281995ns5:OwnedAssets2025-02-012025-12-3108281995ns5:OwnedAssets2024-02-012025-01-3108281995ns5:PatentsTrademarksLicencesConcessionsSimilar2025-02-012025-12-3108281995ns5:PatentsTrademarksLicencesConcessionsSimilar2024-02-012025-01-3108281995ns5:HirePurchaseContracts2025-02-012025-12-3108281995ns5:HirePurchaseContracts2024-02-012025-01-3108281995132025-02-012025-12-3108281995132024-02-012025-01-3108281995142025-02-012025-12-3108281995142024-02-012025-01-3108281995ns10:OrdinaryShareClass12024-02-012025-01-3108281995ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-3108281995ns5:PatentsTrademarksLicencesConcessionsSimilar2025-12-3108281995ns5:PatentsTrademarksLicencesConcessionsSimilar2025-01-3108281995ns5:LandBuildings2025-01-3108281995ns5:PlantMachinery2025-01-3108281995ns5:FurnitureFittings2025-01-3108281995ns5:MotorVehicles2025-01-3108281995ns5:LandBuildings2025-02-012025-12-3108281995ns5:LandBuildings2025-12-3108281995ns5:PlantMachinery2025-12-3108281995ns5:FurnitureFittings2025-12-3108281995ns5:MotorVehicles2025-12-3108281995ns5:LandBuildings2025-01-3108281995ns5:PlantMachinery2025-01-3108281995ns5:FurnitureFittings2025-01-3108281995ns5:MotorVehicles2025-01-3108281995ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3108281995ns5:WithinOneYearns5:CurrentFinancialInstruments2025-01-3108281995ns5:WithinOneYear2025-12-3108281995ns5:WithinOneYear2025-01-3108281995ns5:AcceleratedTaxDepreciationDeferredTax2025-12-3108281995ns5:AcceleratedTaxDepreciationDeferredTax2025-01-3108281995ns5:DeferredTaxation2025-01-3108281995ns5:DeferredTaxation2025-02-012025-12-3108281995ns5:DeferredTaxation2025-12-3108281995ns10:OrdinaryShareClass12025-12-3108281995ns10:OrdinaryShareClass22025-12-3108281995ns5:RetainedEarningsAccumulatedLosses2025-01-3108281995ns5:SharePremium2025-01-31082819952ns10:Director22025-01-31082819952ns10:Director22024-01-31082819952ns10:Director22025-02-012025-12-31082819952ns10:Director22024-02-012025-01-31082819952ns10:Director22025-12-31082819952ns10:Director22025-01-31
REGISTERED NUMBER: 08281995 (England and Wales)












JR PET PRODUCTS LTD

STRATEGIC REPORT,

REPORT OF THE DIRECTORS AND

FINANCIAL STATEMENTS

FOR THE PERIOD

1 FEBRUARY 2025 TO 31 DECEMBER 2025






JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025




Page

Company Information 1

Strategic Report 2

Report of the Directors 3

Report of the Independent Auditors 5

Income Statement 9

Other Comprehensive Income 10

Balance Sheet 11

Statement of Changes in Equity 12

Cash Flow Statement 13

Notes to the Cash Flow Statement 14

Notes to the Financial Statements 15


JR PET PRODUCTS LTD

COMPANY INFORMATION
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025







DIRECTORS: J P Davies
R J Davies
M J Williams
M Hierling
K Jeswani Jeswani





REGISTERED OFFICE: JR Pet Products
Church Bank
Llandovery
SA20 0BA





REGISTERED NUMBER: 08281995 (England and Wales)





AUDITORS: Bevan Buckland Audit Ltd
Chartered Accountants
And Statutory Auditors
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

STRATEGIC REPORT
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

The directors present their strategic report for the period 1 February 2025 to 31 December 2025.

REVIEW OF BUSINESS
JR Pet Products Ltd has delivered another solid performance, achieving sales of £14.59 million across the eleven-month period to 31 December 2025 - reflecting a change in our financial year end. Our unwavering commitment to producing high-quality, unique natural dog treats, coupled with exceptional customer service, remains at the core of everything we do. With over 13,500 Trustpilot reviews and a rating of 4.9 out of 5, we are immensely proud of the reputation we continue to build.

Our strategic focus remains on doing the simple things exceptionally well - speed of delivery, outstanding customer service and above all, unique, high-quality products. This approach continues to resonate strongly with both our retail partners and our growing base of direct consumers.

Independent pet specialist retailers remain the cornerstone of our business, and we are deeply committed to supporting this channel. We believe these partnerships are fundamental to the long-term health of the industry and will continue to invest time and resources into helping them thrive. Alongside this, our direct-to-consumer platform continues to grow, providing not only a significant revenue stream but also invaluable real-time insight into consumer trends and preferences - insight that directly informs our product development and brand strategy.

New product development remained a key area of focus throughout the period. Our procurement team continues to deliver outstanding results and we are pleased with the progress made in expanding our product range with innovative, on-trend offerings that meet the evolving demands of today's pet owner.

We have also continued to develop our in-house systems, particularly on the distribution side, driving further operational efficiencies that will help offset rising input costs - including the increase in employer National Insurance contributions.

The business remains in a strong financial position, with zero debt and healthy retained profits. Maintaining financial discipline has always been central to our strategy, providing the stability to navigate challenges and the agility to pursue new opportunities as they arise.

We would like to thank the entire JR team for their hard work and dedication throughout the period. It is their commitment across every area of the business that underpins our continued success.

Key Performance Indicators
- Net profit margin: 35% (FY24: 37%)
- Gross margin: 54% (FY24: 54%)
- Cash and cash equivalents: £2.97 million
- 754 new B2B customers
- 18,203 new D2C customers

PRINCIPAL RISKS AND UNCERTAINTIES
We remain vigilant in managing key risks, including currency fluctuations, stock shortages, and price volatility. We continue to implement measures to hedge against foreign exchange risks during specific periods and work closely with suppliers to ensure consistent and competitive procurement terms.

ON BEHALF OF THE BOARD:





J P Davies - Director


26 June 2026

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

REPORT OF THE DIRECTORS
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

The directors present their report with the financial statements of the company for the period 1 February 2025 to 31 December 2025.

PRINCIPAL ACTIVITY
The principal activity of the company in the period under review was that of selling premium, natural chews and treats for dogs.

DIVIDENDS
A dividend of £1,150,000 was issued to the parent company on 7th July 2025, AlphaPet UK Ventures Limited. The directors recommend that no final dividend be paid on these shares.

The total distribution of dividends for the year ended 31st December 2025 will be £13,598,883.

DIRECTORS
The directors shown below have held office during the whole of the period from 1 February 2025 to the date of this report.

J P Davies
R J Davies
M J Williams
M Hierling
K Jeswani Jeswani

POLITICAL DONATIONS AND EXPENDITURE
During the year, the company made non-political donations totalling £18,111, supporting various local charitable organisations and community initiatives.

STATEMENT OF DIRECTORS' RESPONSIBILITIES
The directors are responsible for preparing the Strategic Report, the Report of the Directors and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

-select suitable accounting policies and then apply them consistently;
-make judgements and accounting estimates that are reasonable and prudent;
-prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

STATEMENT AS TO DISCLOSURE OF INFORMATION TO AUDITORS
So far as the directors are aware, there is no relevant audit information (as defined by Section 418 of the Companies Act 2006) of which the company's auditors are unaware, and each director has taken all the steps that he or she ought to have taken as a director in order to make himself or herself aware of any relevant audit information and to establish that the company's auditors are aware of that information.

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

REPORT OF THE DIRECTORS
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025


AUDITORS
The auditors, Bevan Buckland Audit Ltd, will be proposed for re-appointment at the forthcoming Annual General Meeting.

ON BEHALF OF THE BOARD:





J P Davies - Director


26 June 2026

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
JR PET PRODUCTS LTD

Opinion
We have audited the financial statements of Jr Pet Products Ltd (the 'company') for the period ended 31 December 2025 which comprise the Income Statement, Other Comprehensive Income, Balance Sheet, Statement of Changes in Equity, Cash Flow Statement and Notes to the Cash Flow Statement, Notes to the Financial Statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:
-give a true and fair view of the state of the company's affairs as at 31 December 2025 and of its profit for the period then ended;
-have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
-have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information
The directors are responsible for the other information. The other information comprises the information in the Strategic Report and the Report of the Directors, but does not include the financial statements and our Report of the Auditors thereon.

Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the Strategic Report and the Report of the Directors for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the Strategic Report and the Report of the Directors have been prepared in accordance with applicable legal requirements.

Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the Strategic Report or the Report of the Directors.

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:
- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or
- the financial statements are not in agreement with the accounting records and returns; or
- certain disclosures of directors' remuneration specified by law are not made; or
- we have not received all the information and explanations we require for our audit.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
JR PET PRODUCTS LTD


Responsibilities of directors
As explained more fully in the Statement of Directors' Responsibilities set out on page three, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
JR PET PRODUCTS LTD


Auditors' responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue a Report of the Auditors that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, and then, design and perform audit procedures responsive to those risks, including obtaining audit evidence that is sufficient and appropriate to provide a basis for our opinion.

We discussed our audit independence complying with the Revised Ethical Standard 2024 with the engagement team members whilst planning the audit and continually monitored our independence throughout the process.

In identifying and assessing risks of material misstatement in respect of irregularities, including fraud and non-compliance with laws and regulations, our procedures included the following:

- enquiring of management, including obtaining and reviewing supporting documentation, concerning the Company's policies and procedures relating to;

- identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance;

- detecting and responding to the risks of fraud and whether they have knowledge of any actual. suspected or alleged fraud;

- the internal controls established to mitigate risks related to fraud or non-compliance with laws and regulations;

- discussing among the engagement team how and where fraud might occur in the Financial Statements and any potential indicators of fraud. As part of this discussion, we identified potential for fraud in the following areas; Indication of impairment and valuation estimates; and Revenue recognition;

- obtaining an understanding of the legal and regulatory frameworks that the Company operates in, focusing on those laws and regulations that had a direct effect on the Financial Statements or that had a fundamental effect on the operations of the Company. The key laws and regulations we considered in this context included the UK Companies Act and relevant tax legislation.

In addition to the above, our procedures to respond to risks identified included the following:

- reviewing the financial statement disclosures and testing to supporting documentation to assess compliance with relevant laws and regulations;

- enquiring of management concerning actual and potential litigation and claims; performing analytical procedures to identify any unusual or unexpected relationships that may indicate risks of material misstatement due to fraud;

- reading minutes of meetings of those charged with governance and reviewing correspondence with HMRC; and

- in addressing the risk of fraud through management override of controls, testing the appropriateness of journal entries and other adjustments;

- assessing whether the judgements made in making accounting estimates are indicative of a potential bias; and evaluating the business rationale of any significant transactions that are unusual or outside the normal course of business.

We also communicated relevant identified laws and regulations and potential fraud risks to all engagement team members and remained alert to any indications of fraud or non-compliance with laws and regulations throughout the audit.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our Report of the Auditors.

REPORT OF THE INDEPENDENT AUDITORS TO THE MEMBERS OF
JR PET PRODUCTS LTD


Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in a Report of the Auditors and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.




Llinos Williams (Senior Statutory Auditor)
for and on behalf of Bevan Buckland Audit Ltd
Chartered Accountants
And Statutory Auditors
Ground Floor Cardigan House
Castle Court
Swansea Enterprise Park
Swansea
SA7 9LA

2 July 2026

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

INCOME STATEMENT
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

Period Year Ended
1.2.25 to 31.12.25 31.1.25
Notes £    £    £    £   

TURNOVER 3 14,586,686 16,594,030

Cost of sales 6,641,677 7,720,736
GROSS PROFIT 7,945,009 8,873,294

Administrative expenses 2,811,689 3,441,864
OPERATING PROFIT 5 5,133,320 5,431,430

Income from fixed asset investments - 26,679
Interest receivable and similar income 56,129 395,765
56,129 422,444
5,189,449 5,853,874
Gain/loss on revaluation of investments - 353,834
5,189,449 6,207,708

Interest payable and similar expenses 6 9,245 35,375
PROFIT BEFORE TAXATION 5,180,204 6,172,333

Tax on profit 7 136,389 1,474,932
PROFIT FOR THE FINANCIAL PERIOD 5,043,815 4,697,401

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

OTHER COMPREHENSIVE INCOME
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

Period
1.2.25
to Year Ended
31.12.25 31.1.25
Notes £    £   

PROFIT FOR THE PERIOD 5,043,815 4,697,401


OTHER COMPREHENSIVE INCOME
Revaluation reserve - (76,500 )
Income tax relating to other comprehensive
income

-

-
OTHER COMPREHENSIVE INCOME FOR THE
PERIOD, NET OF INCOME TAX

-

(76,500

)
TOTAL COMPREHENSIVE INCOME FOR THE
PERIOD

5,043,815

4,620,901

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

BALANCE SHEET
31 DECEMBER 2025

2025 2025
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 9 254,320 292,642
Tangible assets 10 1,751,082 1,858,643
2,005,402 2,151,285

CURRENT ASSETS
Stocks 11 3,167,136 2,191,864
Debtors 12 2,138,150 13,326,081
Cash at bank and in hand 2,972,807 1,570,633
8,278,093 17,088,578
CREDITORS
Amounts falling due within one year 13 902,452 1,277,818
NET CURRENT ASSETS 7,375,641 15,810,760
TOTAL ASSETS LESS CURRENT LIABILITIES 9,381,043 17,962,045

PROVISIONS FOR LIABILITIES 15 90,698 116,632
NET ASSETS 9,290,345 17,845,413

CAPITAL AND RESERVES
Called up share capital 16 100 100
Share premium 17 49,970 49,970
Retained earnings 17 9,240,275 17,795,343
SHAREHOLDERS' FUNDS 9,290,345 17,845,413

The financial statements were approved by the Board of Directors and authorised for issue on 26 June 2026 and were signed on its behalf by:





R J Davies - Director


JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

STATEMENT OF CHANGES IN EQUITY
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

Called up
share Retained Share Other Total
capital earnings premium reserves equity
£    £    £    £    £   
Balance at 1 February 2024 100 13,897,942 49,970 76,500 14,024,512

Changes in equity
Dividends - (800,000 ) - - (800,000 )
Total comprehensive income - 4,697,401 - (76,500 ) 4,620,901
Balance at 31 January 2025 100 17,795,343 49,970 - 17,845,413

Changes in equity
Dividends - (13,598,883 ) - - (13,598,883 )
Total comprehensive income - 5,043,815 - - 5,043,815
Balance at 31 December 2025 100 9,240,275 49,970 - 9,290,345

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

CASH FLOW STATEMENT
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

Period
1.2.25
to Year Ended
31.12.25 31.1.25
Notes £    £   
Cash flows from operating activities
Cash generated from operations 1 4,147,179 5,162,345
Interest element of hire purchase or finance
lease rental payments paid

-

(1,794

)
Finance costs paid (9,245 ) (33,581 )
Tax paid (1,625,000 ) (1,925,000 )
Net cash from operating activities 2,512,934 3,201,970

Cash flows from investing activities
Purchase of tangible fixed assets (16,889 ) (104,836 )
Sale of tangible fixed assets - 70,287
Sale of investment property - 355,000
Cash paid into current asset investment - (650,000 )
Proceeds from current asset investment - 9,522,248
Investment management fees - (6,705 )
Interest received 56,129 422,444
Net cash from investing activities 39,240 9,608,438

Cash flows from financing activities
Loan to parent company - (12,448,883 )
Capital repayments in year - (18,750 )
Amount introduced by directors - 83,000
Equity dividends paid (1,150,000 ) (800,000 )
Net cash from financing activities (1,150,000 ) (13,184,633 )

Increase/(decrease) in cash and cash equivalents 1,402,174 (374,225 )
Cash and cash equivalents at beginning of
period

2

1,570,633

1,944,858

Cash and cash equivalents at end of period 2 2,972,807 1,570,633

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE CASH FLOW STATEMENT
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

1. RECONCILIATION OF PROFIT BEFORE TAXATION TO CASH GENERATED FROM OPERATIONS

Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Profit before taxation 5,180,204 6,172,333
Depreciation charges 162,773 207,321
Profit on disposal of fixed assets - (60,988 )
Gain on revaluation of fixed assets - (353,834 )
Finance costs 9,245 35,375
Finance income (56,129 ) (422,444 )
5,296,093 5,577,763
(Increase)/decrease in stocks (975,272 ) 190,732
Increase in trade and other debtors (238,693 ) (335,954 )
Increase/(decrease) in trade and other creditors 65,051 (270,196 )
Cash generated from operations 4,147,179 5,162,345

2. CASH AND CASH EQUIVALENTS

The amounts disclosed on the Cash Flow Statement in respect of cash and cash equivalents are in respect of these Balance Sheet amounts:

Period ended 31 December 2025
31.12.25 1.2.25
£    £   
Cash and cash equivalents 2,972,807 1,570,633
Year ended 31 January 2025
31.1.25 1.2.24
£    £   
Cash and cash equivalents 1,570,633 1,944,858


3. ANALYSIS OF CHANGES IN NET FUNDS

At 1.2.25 Cash flow At 31.12.25
£    £    £   
Net cash
Cash at bank and in hand 1,570,633 1,402,174 2,972,807
1,570,633 1,402,174 2,972,807
Total 1,570,633 1,402,174 2,972,807

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

1. STATUTORY INFORMATION

Jr Pet Products Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

The company is included in the consolidated financial statements of its parent company, AlphaPet UK Ventures Limited, who registered office is, Danworth House Jobs Lane, Sayers Common, Hassocks, England, BN6 9HE.

Due to non-coterminous year ends, the company's financial statements will be included in the consolidated financial statements of the parent company starting from 31 December 2025.

Going concern
The financial statements have been prepared on a going concern basis, which the directors consider to be the most appropriate basis of preparation. At the balance sheet date, the directors do not consider there to be any circumstances that affect the business' ability to trade for the foreseeable future.

Related party exemption
The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:

- The amount of revenue can be reliably measured;
- It is probable that future economic benefits will flow to the entity;
- and specific criteria have been met for each of the company's activities.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of 10 years.

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - 2% on cost
Plant and Machinery - 20% on cost
Fixtures and fittings - 20% on cost
Motor vehicles - 20% on cost

All property, plant and equipment use the cost model and are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

Cost comprises the purchase price of the asset and expenditure directly attributable to the acquisition of the item.

A fixed asset is derecognised upon disposal or when no future economic benefits are expected to arise from the continued use of the asset. The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to the income statement.

Impairment of fixed assets
The company performs impairment testing where there are any indicators of impairment. Impairment is calculated as the difference between the carrying value and the recoverable value of the asset.

Recoverable value is the higher of net realisable value and estimated value in use at the date the impairment loss is recognised. Value in use represents the present value of expected future discounted cash flows. If incurred, impairment is recognised immediately in the income statement.

Where an impairment loss subsequently reverses, the carrying value of the asset is increased to the revised estimate of the recoverable amount, but so that the increased carrying value does not exceed the carrying value that would have been determined if no impairment loss had been recognised for the asset in prior years.

A reversal of an impairment loss is recognised immediately as a credit to the income statement.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in fair value is recognised in profit or loss.

Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition.

The company recognises stock in its accounting system at the date the goods are physically received into the warehouse, rather than at the date of supplier invoicing. This reflects the point at which control of the goods transfers to the company and the associated obligations arise, in line with the company’s inventory recognition principles.

At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in the profit and loss account.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies
Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Leases
Rentals payable under operating leases, including any lease incentives received, are charged to income on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the lease asset are consumed.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued

Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Creditors
Short term trade creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Debtors
Short term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Financial Instruments
The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' and Section 12 'Other Financial Instruments Issues' of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset's original effective interest rate. The impairment loss is recognised in profit or loss

If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the company transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Basic financial liabilities
Basic financial liabilities, including creditors, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.


JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

2. ACCOUNTING POLICIES - continued
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities
Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.

Significant judgements and estimates
Preparation of the financial statements requires management to make significant judgements and estimates. There are no items in the financial statements where these judgments and estimates have been made.

Dividends
An amount of £13,598,883 (Jan-25: £800,000) was issued to the parent company during this financial year.

Dividends are recognised as a reduction in equity in the period in which they are appropriately authorised and are no longer at the Company’s discretion.

Final dividends are recognised when approved by shareholders; interim dividends are recognised when paid or unconditionally declared.

Dividends are measured at the amount approved and presented as distributions in the statement of changes in equity.

Where dividends are settled by set-off against amounts due from group undertakings, the distribution is measured at the dividend amount and the receivable is reduced on a gross basis where a legally enforceable right of set-off exists and settlement on a net basis is intended.

Dividends declared after the reporting date are not recognised as liabilities at that date and are disclosed as non-adjusting events where material. Dividends are declared only out of distributable profit.

Employee benefits
The cost of shore-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of he cost of stock of fixed asset.

The cost of any unused holiday entitlement is recognised in the period in which the employee's services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employee or to provide termination benefits.

3. TURNOVER

The turnover and profit before taxation are attributable to the one principal activity of the company.

An analysis of turnover by geographical market is given below:

Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
United Kingdom 14,255,290 16,161,712
Europe 206,727 288,708
International 124,669 143,610
14,586,686 16,594,030

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

4. EMPLOYEES AND DIRECTORS
Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Wages and salaries 1,147,029 1,595,360
Social security costs 125,272 146,510
Other pension costs 17,899 68,587
1,290,200 1,810,457

The average number of employees during the period was as follows:
Period
1.2.25
to Year Ended
31.12.25 31.1.25

Administration and support 9 8
Marketing and sales 5 6
Distribution 26 38
40 52

Included within salary costs and other costs in the profit and loss account are amounts paid to key management personnel amounting to £403,459 (Jan-25: £659,105).

Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Directors' remuneration 208,728 448,362

Information regarding the highest paid director is as follows:
Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Emoluments etc 116,783 240,704

5. OPERATING PROFIT

The operating profit is stated after charging/(crediting):

Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Hire of plant and machinery - 804
Other operating leases 27,500 31,072
Depreciation - owned assets 124,450 165,516
Profit on disposal of fixed assets - (60,988 )
Patents and licences amortisation 38,322 41,806
Auditors' remuneration 15,950 14,500

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

6. INTEREST PAYABLE AND SIMILAR EXPENSES
Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Hire purchase - 1,794
Other interest 987 -
Foreign currency (gain)/loss 8,258 33,581
9,245 35,375

7. TAXATION

Analysis of the tax charge
The tax charge on the profit for the period was as follows:
Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Current tax:
UK corporation tax 162,323 1,524,426

Deferred tax (25,934 ) (49,494 )
Tax on profit 136,389 1,474,932

Tax effects relating to effects of other comprehensive income

There were no tax effects for the period ended 31 December 2025.

2025
Gross Tax Net
£    £    £   
Revaluation reserve (76,500 ) - (76,500 )

8. DIVIDENDS
Period
1.2.25
to Year Ended
31.12.25 31.1.25
£    £   
Ordinary shares of £1 each
Interim 13,598,883 800,000

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

9. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 February 2025
and 31 December 2025 418,060
AMORTISATION
At 1 February 2025 125,418
Amortisation for period 38,322
At 31 December 2025 163,740
NET BOOK VALUE
At 31 December 2025 254,320
At 31 January 2025 292,642

10. TANGIBLE FIXED ASSETS
Fixtures
Freehold Plant and and Motor
property Machinery fittings vehicles Totals
£    £    £    £    £   
COST
At 1 February 2025 1,393,233 368,855 389,536 373,288 2,524,912
Additions - 3,495 13,394 - 16,889
At 31 December 2025 1,393,233 372,350 402,930 373,288 2,541,801
DEPRECIATION
At 1 February 2025 68,695 195,582 196,047 205,945 666,269
Charge for period 25,542 31,883 36,345 30,680 124,450
At 31 December 2025 94,237 227,465 232,392 236,625 790,719
NET BOOK VALUE
At 31 December 2025 1,298,996 144,885 170,538 136,663 1,751,082
At 31 January 2025 1,324,538 173,273 193,489 167,343 1,858,643

11. STOCKS
2025 2025
£    £   
Stocks 3,167,136 2,191,864

12. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2025
£    £   
Trade debtors 690,481 622,158
Amounts owed by group undertakings - 12,448,883
Other debtors 284,426 184,428
Tax 1,022,259 -
Prepayments 140,984 70,612
2,138,150 13,326,081

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

13. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2025
£    £   
Trade creditors 552,650 324,599
Tax - 440,418
Social security and other taxes 35,838 26,525
VAT 223,526 407,204
Other creditors 53,054 38,806
Accrued expenses 37,384 40,266
902,452 1,277,818

14. LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:
2025 2025
£    £   
Within one year 30,000 30,000

15. PROVISIONS FOR LIABILITIES
2025 2025
£    £   
Deferred tax
Accelerated capital allowances 90,698 116,632

Deferred
tax
£   
Balance at 1 February 2025 116,632
Credit to Income Statement during period (25,934 )
Balance at 31 December 2025 90,698

16. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2025
value: £    £   
80 Ordinary £1 80 80
20 Ordinary A £1 20 20
100 100

The Ordinary shares and A Ordinary shares have equal rights in respect of voting, dividends and distributions of capital.

JR PET PRODUCTS LTD (REGISTERED NUMBER: 08281995)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 1 FEBRUARY 2025 TO 31 DECEMBER 2025

17. RESERVES
Retained Share
earnings premium Totals
£    £    £   

At 1 February 2025 17,795,343 49,970 17,845,313
Profit for the period 5,043,815 5,043,815
Dividends (13,598,883 ) (13,598,883 )
At 31 December 2025 9,240,275 49,970 9,290,245

Retained earnings represent the cumulative profits and losses of the company after dividends and other distributions to shareholders.

The share premium reserve represents premiums arising on the issue of shares above their nominal value and is generally non-distributable.

18. PENSION COMMITMENTS

The company operates a defined contribution pension scheme. The pension cost charge for the year represents contributions payable by the company to the scheme and amounted to £19,110 (Jan-25: £119,907).Of this amount, £1,211 relate to director's pension.

Contributions totalling £3,279 (Jan-25: £2,711) were payable to the scheme at the end of the year and are included in creditors.

19. ULTIMATE PARENT COMPANY

On 16th January 2025, JR Pet Products Limited was acquired by AlphaPet UK Ventures Ltd who are now the parent company and hold 100% of the issued share capital.

The ultimate parent company is AlphaPet Ventures GmbH, a company registered in Germany whose registered office is Landsberger Str. 234. 80687 Munich,Germany.

20. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the period ended 31 December 2025 and the year ended 31 January 2025:

2025 2025
£    £   
J P Davies
Balance outstanding at start of period - 83,000
Amounts repaid - (83,000 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of period - -